| Literature DB >> 23840267 |
Xiaoyan Gao1, Mingxing Guo, Long Peng, Baosheng Zhao, Jiankun Su, Haiyu Liu, Li Zhang, Xu Bai, Yanjiang Qiao.
Abstract
Fever is one of the most common clinical symptoms of many diseases. Qingkailing (QKL) injection is widely used in China as a clinical emergency medicine due to its good antipyretic effects. It is a herbal formula which is composed by eight kinds of traditional Chinese medicines (TCM). As a kind of typical multiple constituents and multiple actions of TCM, it is very difficult to elaborate the antipyretic mechanism by conventional pharmacological method. Metabonomics technique provides beneficial tool for this challenge. In this study, an ultra performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC Q-TOF/MS) metabonomics method was developed to explore the changing process of biochemical substances in rats of yeast-induced pyrexia. Partial least squares discriminate analysis (PLS-DA) was used to distinguish the normal control group, the pyrexia model group, and the pyrexia model group treated by QKL injection. The potential biomarkers related to pyrexia were confirmed and identified. MetPA was used to find the possible metabolic pathways. The results indicated that the antipyretic effect of QKL injection on yeast-induced pyrexia rats was performed by repairing the perturbed metabolism of amino acids.Entities:
Year: 2013 PMID: 23840267 PMCID: PMC3690234 DOI: 10.1155/2013/864747
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Results of rectal temperature in CG, PG, and TG. Data were expressed by independent sample t-test. aa P < 0.01, a P < 0.05 compared with CG. bb P < 0.01, b P < 0.05 compared with PG. c P < 0.05 compared with CG.
Figure 2PLS-DA score plot obtained from CG (▲), PG (◆), and TG (●) at 4 h (a) and 8 h (b).
Metabolites selected as biomarkers characterized in urine profiles and their change trends.
| No. |
|
| Metabolites | Trend in PGa | Trend in TGb | VIP |
|---|---|---|---|---|---|---|
| 1 | 0.5222 | 104.1074 | 4-Aminobutyric acid | ↑*** | ↓*** | 4.73 |
| 2 | 0.5549 | 118.0867 | Glycocyamine | ↑*** | ↓** | 5.08 |
| 3 | 0.5648 | 114.0667 | Creatinine | ↑ | ↓** | 4.66 |
| 4 | 0.6110 | 143.0819 | Ectoine | ↑* | ↓* | 5.14 |
| 5 | 0.6440 | 176.0978 | Citrulline | ↑*** | ↓*** | 3.51 |
| 6 | 0.6686 | 325.1131 | Difructose anhydride I | ↑** | ↓ | 3.95 |
| 7 | 0.6730 | 127.0478 | Imidazoleacetic acid | ↑*** | ↓*** | 3.54 |
| 8 | 0.6877 | 259.0931 | 3-Methyluridine | ↑*** | ↓*** | 4.17 |
| 9 | 0.7837 | 130.0502 | 1-Pyrroline-4-hydroxy-2-carboxylate | ↓ | ↑*** | 3.98 |
| 10 | 1.2175 | 116.0709 | Proline | ↓** | ↑* | 3.38 |
| 11 | 1.5638 | 126.0666 | 5-Methylcytosine | ↑* | ↓*** | 3.07 |
| 12 | 2.6807 | 227.1029 | 3-Hydroxykynurenine | ↑ | ↓*** | 2.18 |
| 13 | 2.7929 | 220.1183 | Pantothenic acid | ↑ | ↓* | 5.10 |
| 14 | 2.8259 | 384.1149 | Succinyladenosine | ↑*** | ↓*** | 6.10 |
| 15 | 3.3189 | 205.0966 | Tryptophan | ↑*** | ↓*** | 4.84 |
| 16 | 3.4148 | 206.0452 | Xanthurenate | ↓*** | ↑*** | 6.88 |
| 17 | 3.6484 | 160.0971 | Methylbutyrylglycine | ↓*** | ↑ | 3.10 |
| 18 | 4.2819 | 180.0658 | Hippurate | ↓* | ↑ | 3.53 |
| 19 | 4.8699 | 162.0553 | Indole-3-carboxylic acid | ↑ | ↓** | 2.38 |
| 20 | 10.8441 | 274.2741 | Hexadecasphinganine | ↑* | ↓** | 4.06 |
| 21 | 11.3671 | 812.4414 | PE(22:6/20:4) | ↑*** | ↓*** | 5.39 |
aChange trend compared with CG.
bChange trend compared with PG.
The levels of potential biomarkers were labeled with (↓) downregulated and (↑) upregulated (*P < 0.05; **P < 0.01; ***P < 0.001; one-way ANOVA followed by independent samples t-test).
Figure 3Summary of pathway analysis. (1) Tryptophan metabolism; (2) arginine and proline metabolism; (3) alanine, aspartate and glutamate metabolism; (4) glycine, serine, and threonine metabolism; (5) butanoate metabolism; (6) pantothenate and CoA biosynthesis; (7) histidine metabolism; (8) aminoacyl-tRNA biosynthesis; (9) beta-alanine metabolism.
Figure 4The perturbed metabolic pathways in response to the antipyretic mechanism of QKL injection.